Clinical trial
Pilot Study of a Multi-Drug Regimen for Severe Pulmonary Fibrosis in…
NCT00467831 · National Human Genome Research Institute (NHGRI), NIH · Terminated
Key facts
| NCT number | NCT00467831 |
|---|---|
| Title | Pilot Study of a Multi-Drug Regimen for Severe Pulmonary Fibrosis in Hermansky-Pudlak Syndrome |
| Official title | Pilot Study of a Multi-Drug Regimen for Severe Pulmonary Fibrosis in Hermansky-Pudlak Syndrome |
| Lead sponsor | National Human Genome Research Institute (NHGRI), NIH |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Hermansky-Pudlak Syndrome (HPS), Pulmonary Fibrosis, Oculocutaneous Albinism, Platelet Storage Pool Deficiency, Metabolic Disease |
| Intervention type | Drug |
| Interventions | Losartan, Zileuton, N-Acetylcysteine, Pravastatin, Erythromycin |
| Enrollment | 3 |
| Start date | Apr 1, 2007 |
| Primary completion | Nov 1, 2012 |
| Completion | Nov 1, 2012 |
| First posted | May 1, 2007 |
| Last update posted | Aug 2, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: